FDA Personal Use Drug Import Policy Being Examined By Reps. Tauzin, Dingell
Executive Summary
The House Energy & Commerce Committee wants FDA, the Customs Service and the Drug Enforcement Administration to provide a list of all controlled substances brought into the U.S. under FDA's "personal use" exemption import policy.
You may also be interested in...
House Import Bill Shifts Burden To FDA; Rep. Dingell Opposes, Citing PDMA
The House-passed "Drug Importation Fairness Act" will place "unrealistic burdens" on FDA, Rep. Klink (D-Penn.) maintained during floor debate June 28.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials